Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Atlantic Coastal Acquisition II A | ACAB | 5. nov 2024 | 11.14 | -3.05 |
Atlantic Union Bank | AUB | 5. nov 2024 | 37.86 | +2.21 |
Atlantic Union Bankshares A Pref | AUB-A | 5. nov 2024 | 24.84 | -0.56 |
Atlantica Sustainable Infrastructure | AY | 5. nov 2024 | 22.08 | +0.05 |
Atlanticus | ATLC | 5. nov 2024 | 37.90 | +1.77 |
Atlanticus B Pref | ATLCP | 5. nov 2024 | 22.93 | -0.28 |
Atlas Energy Solutions | AESI | 5. nov 2024 | 20.18 | +1.10 |
Atlas Lithium | ATLX | 5. nov 2024 | 8.97 | -3.65 |
Atlas Pref D | ATCO-D | 5. nov 2024 | 25.14 | +0.38 |
Atlas Pref H | ATCO-H | 5. nov 2024 | 25.04 | +0.16 |
AtlasClear Holdings | ATCH | 5. nov 2024 | 0.16 | -4.43 |
Atlassian A | TEAM | 5. nov 2024 | 221.58 | +1.20 |
Atmos Energy | ATO | 5. nov 2024 | 137.98 | +0.23 |
Atmus Filtration Technologies | ATMU | 5. nov 2024 | 39.50 | +1.62 |
ATN International | ATNI | 5. nov 2024 | 19.76 | -0.80 |
Atomera | ATOM | 5. nov 2024 | 4.48 | -3.45 |
Atossa Therapeutics | ATOS | 5. nov 2024 | 1.40 | -0.71 |
Atour Lifestyle ADR | ATAT | 5. nov 2024 | 26.68 | +1.48 |
ATRenew A ADR | RERE | 5. nov 2024 | 2.46 | +4.68 |
AtriCure | ATRC | 5. nov 2024 | 35.47 | +5.38 |
ATS Corporation | ATS | 5. nov 2024 | 30.76 | +2.29 |
aTyr Pharma | ATYR | 5. nov 2024 | 3.15 | +2.27 |
Auburn National Bank | AUBN | 5. nov 2024 | 21.85 | -0.14 |
Auddia | AUUD | 5. nov 2024 | 0.60 | +2.89 |
AudioCodes | AUDC | 5. nov 2024 | 9.01 | -1.31 |
AudioEye | AEYE | 5. nov 2024 | 22.75 | +4.79 |
Ault Disruptive Technologies SPAC | ADRT | 5. nov 2024 | 11.40 | 0.00 |
Auna S.A.A | AUNA | 5. nov 2024 | 6.60 | 0.00 |
Aura Biosciences | AURA | 5. nov 2024 | 10.29 | +1.18 |
Aura FAT Projects Acquisition A | AFAR | 5. nov 2024 | 11.68 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.